Accendra Health, Inc.
Get $10 bonus on your first $100 deposit for ACH
Get $10 bonus on your first $100 deposit for ACH
Accendra Health, Inc. (ACH) Stock Competitors & Peer Comparison
See (ACH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACH | $2.63 | +6.05% | 201M | -1.96 | -$1.34 | N/A |
| MCK | $884.28 | +1.37% | 109.1B | 25.55 | $34.61 | +0.36% |
| COR | $324.80 | +2.25% | 63.2B | 39.09 | $8.31 | +0.71% |
| CAH | $214.05 | +0.96% | 50.4B | 30.80 | $6.95 | +0.95% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $73.94 | +1.23% | 8.7B | 22.61 | $3.27 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +1.66% |
| PBH | $52.48 | -9.02% | 2.5B | 13.85 | $3.79 | N/A |
| GRDN | $37.99 | +0.98% | 2.4B | 48.71 | $0.78 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
Stock Comparison
ACH vs MCK Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, MCK has a market cap of 109.1B. Regarding current trading prices, ACH is priced at $2.63, while MCK trades at $884.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas MCK's P/E ratio is 25.55. In terms of profitability, ACH's ROE is +7.33%, compared to MCK's ROE of -2.45%. Regarding short-term risk, ACH is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check MCK's competition here
ACH vs COR Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, COR has a market cap of 63.2B. Regarding current trading prices, ACH is priced at $2.63, while COR trades at $324.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas COR's P/E ratio is 39.09. In terms of profitability, ACH's ROE is +7.33%, compared to COR's ROE of +1.01%. Regarding short-term risk, ACH is more volatile compared to COR. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check COR's competition here
ACH vs CAH Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, CAH has a market cap of 50.4B. Regarding current trading prices, ACH is priced at $2.63, while CAH trades at $214.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas CAH's P/E ratio is 30.80. In terms of profitability, ACH's ROE is +7.33%, compared to CAH's ROE of -0.59%. Regarding short-term risk, ACH is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check CAH's competition here
ACH vs ABC Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, ACH is priced at $2.63, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas ABC's P/E ratio is 21.92. In terms of profitability, ACH's ROE is +7.33%, compared to ABC's ROE of +1.01%. Regarding short-term risk, ACH is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check ABC's competition here
ACH vs HSIC Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, HSIC has a market cap of 8.7B. Regarding current trading prices, ACH is priced at $2.63, while HSIC trades at $73.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas HSIC's P/E ratio is 22.61. In terms of profitability, ACH's ROE is +7.33%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, ACH is more volatile compared to HSIC. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check HSIC's competition here
ACH vs PDCO Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, ACH is priced at $2.63, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas PDCO's P/E ratio is 20.48. In terms of profitability, ACH's ROE is +7.33%, compared to PDCO's ROE of +0.06%. Regarding short-term risk, ACH is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check PDCO's competition here
ACH vs PBH Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, PBH has a market cap of 2.5B. Regarding current trading prices, ACH is priced at $2.63, while PBH trades at $52.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas PBH's P/E ratio is 13.85. In terms of profitability, ACH's ROE is +7.33%, compared to PBH's ROE of +0.10%. Regarding short-term risk, ACH is less volatile compared to PBH. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check PBH's competition here
ACH vs GRDN Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, ACH is priced at $2.63, while GRDN trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas GRDN's P/E ratio is 48.71. In terms of profitability, ACH's ROE is +7.33%, compared to GRDN's ROE of +0.28%. Regarding short-term risk, ACH is more volatile compared to GRDN. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check GRDN's competition here
ACH vs OMI Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, ACH is priced at $2.63, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas OMI's P/E ratio is -0.47. In terms of profitability, ACH's ROE is +7.33%, compared to OMI's ROE of +7.33%. Regarding short-term risk, ACH is less volatile compared to OMI. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check OMI's competition here
ACH vs HX Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, ACH is priced at $2.63, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas HX's P/E ratio is -1.84. In terms of profitability, ACH's ROE is +7.33%, compared to HX's ROE of -1.07%. Regarding short-term risk, ACH is less volatile compared to HX. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check HX's competition here
ACH vs GEG Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, GEG has a market cap of 52.2M. Regarding current trading prices, ACH is priced at $2.63, while GEG trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas GEG's P/E ratio is -3.86. In terms of profitability, ACH's ROE is +7.33%, compared to GEG's ROE of -0.21%. Regarding short-term risk, ACH is more volatile compared to GEG. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check GEG's competition here
ACH vs WGRX Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, WGRX has a market cap of 7.2M. Regarding current trading prices, ACH is priced at $2.63, while WGRX trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas WGRX's P/E ratio is -0.07. In terms of profitability, ACH's ROE is +7.33%, compared to WGRX's ROE of +1417.60%. Regarding short-term risk, ACH is less volatile compared to WGRX. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check WGRX's competition here
ACH vs SNYR Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, SNYR has a market cap of 7.2M. Regarding current trading prices, ACH is priced at $2.63, while SNYR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas SNYR's P/E ratio is -0.63. In terms of profitability, ACH's ROE is +7.33%, compared to SNYR's ROE of +0.83%. Regarding short-term risk, ACH is less volatile compared to SNYR. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check SNYR's competition here
ACH vs ZYXI Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, ZYXI has a market cap of 1.7M. Regarding current trading prices, ACH is priced at $2.63, while ZYXI trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas ZYXI's P/E ratio is -0.02. In terms of profitability, ACH's ROE is +7.33%, compared to ZYXI's ROE of -18.07%. Regarding short-term risk, ACH is less volatile compared to ZYXI. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check ZYXI's competition here
ACH vs MEHA Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, MEHA has a market cap of 1M. Regarding current trading prices, ACH is priced at $2.63, while MEHA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas MEHA's P/E ratio is 14.70. In terms of profitability, ACH's ROE is +7.33%, compared to MEHA's ROE of +1.19%. Regarding short-term risk, ACH is less volatile compared to MEHA. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check MEHA's competition here
ACH vs RDGT Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, RDGT has a market cap of 144K. Regarding current trading prices, ACH is priced at $2.63, while RDGT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas RDGT's P/E ratio is -0.07. In terms of profitability, ACH's ROE is +7.33%, compared to RDGT's ROE of +0.42%. Regarding short-term risk, ACH is less volatile compared to RDGT. This indicates potentially lower risk in terms of short-term price fluctuations for ACH.Check RDGT's competition here
ACH vs CVET Comparison April 2026
ACH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 201M. In comparison, CVET has a market cap of 0. Regarding current trading prices, ACH is priced at $2.63, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of -1.96, whereas CVET's P/E ratio is -69.97. In terms of profitability, ACH's ROE is +7.33%, compared to CVET's ROE of -0.06%. Regarding short-term risk, ACH is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for ACH.Check CVET's competition here